Third Rock Ventures, LLC, a Boston, MA-based healthcare venture capital firm, closed fund IV, at $616m.
With Third Rock Ventures IV, LP, the firm will continue to execute on its strategy of creating innovative healthcare companies.
Since launching in 2007, Third Rock has raised $1.9 billion – including Fund IV – for building innovative companies with a particular focus on areas such as oncology, immunology, neurological disorders, cardiovascular disease and rare genetic diseases.
To date, the firm has launched more than 40 companies, which have delivered four products and one device to the market and advanced more than 40 programs in clinical development.
Third Rock also announced today that industry veteran Abbie Celniker, Ph.D., is joining the firm as a partner. Charles Homcy, M.D., previously a venture partner, is becoming a partner. Frank Gentile, Ph.D., Stephen Sherwin, M.D., and Barbara Weber, M.D., who have served as entrepreneurs-in-residence for the firm, are becoming venture partners.
Other partners includes Robert Tepper, Alexis Borisy, Neil Exter, Kevin Gillis, Mark Levin, Craig Muir, Cary Pfeffer, M.D., and Kevin Starr.